Jan 05, 2026
Neumora’s Alzheimer’s Agitation Drug Shows Early Promise

Neumora Therapeutics, Inc. (NASDAQ:NMRA) on Monday shared results from its Phase 1b signal-seeking study of NMRA-511 for Alzheimer’s disease (AD) agitation. NMRA-511 demonstrated a clinically meaningful effect size in people with AD agitation. In the study, NMRA-511 demonstrated a favorable…

Jan 05, 2026
Crinetics Experimental Pill Slashes Hormones In Rare Adrenal Disease Trial

Crinetics Pharmaceuticals Inc. (NASDAQ:CRNX) on Monday shared topline results from the fourth cohort of its Phase 2 congenital adrenal hyperplasia (CAH) study of investigational atumelnant for CAH and adrenocorticotropic hormone (ACTH)-dependent Cushing’s syndrome. CAH is a genetic disease that affects the…

Jan 05, 2026
Zenas BioPharma Touts Phase 3 Win, But Stock Crashes

Zenas BioPharma Inc. (NASDAQ:ZBIO) stock is trading lower on Monday after the company released results from the Phase 3 INDIGO trial of obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD). IgG4-RD is an immune system disorder where the body creates excess IgG4…

Jan 05, 2026
Phillips 66 Makes Strategic UK Bet With Lindsey Refinery Asset Acquisition

Phillips 66 (NYSE:PSX) stock rose Monday, supported by company-specific developments and broader optimism around potential shifts in global oil investment flows. • Phillips 66 stock is trading at elevated levels. What’s next for PSX stock? Investor sentiment was also buoyed after…

Jan 05, 2026
What’s Going On With Tower Semiconductor Stock Monday?

Tower Semiconductor Ltd. (NASDAQ:TSEM) stock rose Monday after the company announced a strategic collaboration with LightIC Technologies to manufacture silicon photonics–based Frequency-Modulated Continuous-Wave (FMCW) LiDAR sensors, targeting automotive, robotics, and emerging "Physical AI" applications. The stock initially rose following the…

Jan 05, 2026
FDA Lifts Hold On GH Research’s Depression Drug Trial After Two Years

The U.S. Food and Drug Administration (FDA) on Monday lifted the clinical hold on GH Research Plc’s (NASDAQ:GHRS) Investigational New Drug Application (IND) for GH001. GH Research stock is showing positive momentum. What’s ahead for GHRS stock? “The FDA clearance…

Jan 05, 2026
Samsung Ramps Up AI Strategy, Warns Of Rising Costs

Samsung Electronics Co. Ltd. (OTC:SSNLF) plans to expand the reach of its Galaxy artificial intelligence features, doubling the number of mobile devices powered by AI, intensifying rivalry with Apple Inc. (NASDAQ:AAPL) iPhones. The South Korean tech giant has already rolled…

Jan 05, 2026
Autoliv Debuts World’s First Foldable Steering Wheel

Autoliv, Inc. (NYSE:ALV) and mobility startup Tensor have jointly created a foldable steering wheel for Tensor’s Robocar, designed to free up cabin space and enhance comfort when the vehicle operates autonomously. This wheel functions normally for manual control, then retracts…

Jan 05, 2026
Mobileye Stock Soars On New Deal To Power Hands-Free Driving At Scale

Mobileye Global Inc. (NASDAQ:MBLY) stock rose on Monday after the company announced that a U.S.-based automaker has selected the Mobileye EyeQ6H to enable advanced driver assistance systems with hands-free driving capabilities on select highways across millions of vehicles worldwide. Details…